Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Rationale for Bcl-xL/Bad peptide complex formation from structure, mutagenesis, and biophysical studies.

A M Petros1, D G Nettesheim, Y Wang

  • 1Pharmaceutical Discovery Division, Abbott Laboratories, Abbott Park, Illinois 60064-6098, USA.

Protein Science : a Publication of the Protein Society
|February 24, 2001
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Enhancing Brain Lesions during Acute Optic Neuritis and/or Longitudinally Extensive Transverse Myelitis May Portend a Higher Relapse Rate in Neuromyelitis Optica Spectrum Disorders.

AJNR. American journal of neuroradiology·2017
Same author

Tract-Specific Diffusion Tensor Imaging in Cervical Spondylotic Myelopathy Before and After Decompressive Spinal Surgery: Preliminary Results.

Clinical neuroradiology·2015
Same author

Myeloid cell leukemia-1 is an important apoptotic survival factor in triple-negative breast cancer.

Cell death and differentiation·2015
Same author

Adoption of electronic health records: a qualitative study of academic and private physicians and health administrators.

Applied clinical informatics·2013
Same author

Epidemiology, outcomes, and mortality predictors of invasive mold infections among transplant recipients: a 10-year, single-center experience.

Transplant infectious disease : an official journal of the Transplantation Society·2013
Same author

Rethinking the regulation of cellular metabolism.

Cold Spring Harbor symposia on quantitative biology·2012

The anti-apoptotic protein Bcl-xL binds peptides from the Bad protein. Increased helix propensity, not additional contacts, enhances binding affinity, leading to improved peptide designs for Bcl-xL interaction.

Area of Science:

  • Molecular Biology
  • Structural Biology
  • Biochemistry

Background:

  • The anti-apoptotic protein Bcl-xL regulates programmed cell death.
  • Understanding Bcl-xL interactions is crucial for developing therapeutics targeting apoptosis.

Purpose of the Study:

  • To elucidate the structural basis of Bcl-xL binding to a 25-residue peptide from the Bad protein.
  • To investigate the factors contributing to the enhanced affinity of longer Bad peptides for Bcl-xL.

Main Methods:

  • Nuclear Magnetic Resonance (NMR) spectroscopy was used to determine the three-dimensional structure of the Bcl-xL/Bad peptide complex.
  • Site-directed mutagenesis experiments were performed to assess the contribution of specific interactions.
  • Peptide design and synthesis were employed to create variants with altered properties.

Related Experiment Videos

Main Results:

  • The structure of Bcl-xL complexed with the Bad 25-mer peptide revealed similarities and differences compared to previously studied complexes.
  • Additional interactions were observed between the Bad 25-mer and Bcl-xL, but these did not fully explain the increased binding affinity.
  • Increased helix propensity of the Bad 25-mer was identified as the primary driver for its enhanced affinity.
  • Designed 16-residue peptides with high helix propensity showed increased affinity for Bcl-xL.

Conclusions:

  • Helix propensity is a critical determinant of binding affinity for Bcl-xL.
  • Peptide design strategies focusing on helix propensity can yield high-affinity binders for Bcl-xL.
  • These findings offer insights into the modulation of apoptosis by Bcl-xL-interacting peptides.